157 related articles for article (PubMed ID: 35093861)
21. Survival efficacy of the combination of the methioninase gene and methioninase in a lung cancer orthotopic model.
Miki K; Xu M; An Z; Wang X; Yang M; Al-Refaie W; Sun X; Baranov E; Tan Y; Chishima T; Shimada H; Moossa AR; Hoffman RM
Cancer Gene Ther; 2000 Feb; 7(2):332-8. PubMed ID: 10770644
[TBL] [Abstract][Full Text] [Related]
22. Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells.
Yamamoto J; Han Q; Inubushi S; Sugisawa N; Hamada K; Nishino H; Miyake K; Kumamoto T; Matsuyama R; Bouvet M; Endo I; Hoffman RM
Biochem Biophys Res Commun; 2020 Dec; 533(4):1034-1038. PubMed ID: 33019978
[TBL] [Abstract][Full Text] [Related]
23. Oral Installation of Recombinant Methioninase-producing
Kubota Y; Han Q; Hamada K; Aoki Y; Masaki N; Obara K; Baranov A; Bouvet M; Tsunoda T; Hoffman RM
Cancer Genomics Proteomics; 2022; 19(6):683-691. PubMed ID: 36316039
[TBL] [Abstract][Full Text] [Related]
24. A review on L-methioninase in cancer therapy: Precision targeting, advancements and diverse applications for a promising future.
Javia BM; Gadhvi MS; Vyas SJ; Ghelani A; Wirajana N; Dudhagara DR
Int J Biol Macromol; 2024 Apr; 265(Pt 2):130997. PubMed ID: 38508568
[TBL] [Abstract][Full Text] [Related]
25. Chronic Treatment of an Advanced Prostate-cancer Patient With Oral Methioninase Resulted in Long-term Stabilization of Rapidly Rising PSA Levels.
Han Q; Hoffman RM
In Vivo; 2021; 35(4):2171-2176. PubMed ID: 34182494
[TBL] [Abstract][Full Text] [Related]
26. Methioninase Gene Therapy.
Hoffman RM; Miki K; Al-Refaie W; Xu M; Tan Y
Methods Mol Biol; 2019; 1866():173-197. PubMed ID: 30725416
[TBL] [Abstract][Full Text] [Related]
27. Methionine Restriction Increases Exosome Production and Secretion in Breast Cancer Cells.
Inubushi S; Kunihisa T; Mizumoto S; Inoue S; Miki M; Suetsugu A; Tanino H; Hoffman RM
Cancer Genomics Proteomics; 2023; 20(5):412-416. PubMed ID: 37643781
[TBL] [Abstract][Full Text] [Related]
28. Methioninase gene therapy of human cancer cells is synergistic with recombinant methioninase treatment.
Miki K; Al-Refaie W; Xu M; Jiang P; Tan Y; Bouvet M; Zhao M; Gupta A; Chishima T; Shimada H; Makuuchi M; Moossa AR; Hoffman RM
Cancer Res; 2000 May; 60(10):2696-702. PubMed ID: 10825143
[TBL] [Abstract][Full Text] [Related]
29. Oral Methioninase for Covid-19 Methionine-restriction Therapy.
Hoffman RM; Han Q
In Vivo; 2020 Jun; 34(3 Suppl):1593-1596. PubMed ID: 32503816
[TBL] [Abstract][Full Text] [Related]
30. Methioninase: a therapeutic for diseases related to altered methionine metabolism and transmethylation: cancer, heart disease, obesity, aging, and Parkinson's disease.
Hoffman RM
Hum Cell; 1997 Mar; 10(1):69-80. PubMed ID: 9234067
[TBL] [Abstract][Full Text] [Related]
31. Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model.
Higuchi T; Han Q; Miyake K; Oshiro H; Sugisawa N; Tan Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
Biochem Biophys Res Commun; 2020 Feb; 523(1):135-139. PubMed ID: 31839218
[TBL] [Abstract][Full Text] [Related]
32. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Murakami T; Li S; Han Q; Tan Y; Kiyuna T; Igarashi K; Kawaguchi K; Hwang HK; Miyake K; Singh AS; Nelson SD; Dry SM; Li Y; Hiroshima Y; Lwin TM; DeLong JC; Chishima T; Tanaka K; Bouvet M; Endo I; Eilber FC; Hoffman RM
Oncotarget; 2017 May; 8(22):35630-35638. PubMed ID: 28404944
[TBL] [Abstract][Full Text] [Related]
33. Exploiting methionine restriction for cancer treatment.
Chaturvedi S; Hoffman RM; Bertino JR
Biochem Pharmacol; 2018 Aug; 154():170-173. PubMed ID: 29733806
[TBL] [Abstract][Full Text] [Related]
34. Methioninase Cell-Cycle Trap Cancer Chemotherapy.
Hoffman RM; Yano S; Igarashi K
Methods Mol Biol; 2019; 1866():133-148. PubMed ID: 30725413
[TBL] [Abstract][Full Text] [Related]
35. Can dietary methionine restriction increase the effectiveness of chemotherapy in treatment of advanced cancer?
Epner DE
J Am Coll Nutr; 2001 Oct; 20(5 Suppl):443S-449S; discussion 473S-475S. PubMed ID: 11603655
[TBL] [Abstract][Full Text] [Related]
36. Development of Recombinant Methioninase for Cancer Treatment.
Hoffman RM; Tan Y; Li S; Han Q; Yagi S; Takakura T; Takimoto A; Inagaki K; Kudou D
Methods Mol Biol; 2019; 1866():107-131. PubMed ID: 30725412
[TBL] [Abstract][Full Text] [Related]
37. Microbial L-methioninase: production, molecular characterization, and therapeutic applications.
El-Sayed AS
Appl Microbiol Biotechnol; 2010 Mar; 86(2):445-67. PubMed ID: 20146062
[TBL] [Abstract][Full Text] [Related]
38. Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells In Vitro.
Tan Y; Xu M; Hoffman RM
Anticancer Res; 2010 Apr; 30(4):1041-6. PubMed ID: 20530407
[TBL] [Abstract][Full Text] [Related]
39. Methionine restriction selectively targets thymidylate synthase in prostate cancer cells.
Lu S; Chen GL; Ren C; Kwabi-Addo B; Epner DE
Biochem Pharmacol; 2003 Sep; 66(5):791-800. PubMed ID: 12948860
[TBL] [Abstract][Full Text] [Related]
40. Pilot Phase I Clinical Trial of Methioninase on High-Stage Cancer Patients: Rapid Depletion of Circulating Methionine.
Hoffman RM; Tan Y; Li S; Han Q; Zavala J; Zavala J
Methods Mol Biol; 2019; 1866():231-242. PubMed ID: 30725419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
